067080 — Dae Hwa Pharm Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapFalling Star

Annual balance sheet for Dae Hwa Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	ARS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	6,390	12,302	4,722	5,838	2,763
Net Total Accounts Receivable
Net Total Receivables	18,014	18,236	19,451	24,536	21,423
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	50,926	56,139	51,213	65,220	61,607
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	68,778	68,245	89,857	94,351	91,702
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	175,047	177,376	199,056	219,163	205,884
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	77,608	75,335	83,260	127,948	117,693
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	93,068	97,702	121,064	145,931	133,885
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	81,979	79,674	77,993	73,232	71,999
Total Liabilities & Shareholders' Equity	175,047	177,376	199,056	219,163	205,884
Total Common Shares Outstanding